Eikon Therapeutics
Business Services · California, United States · 300 Employees
View Company Info for Free
About
Headquarters
3929 Point Eden Way, Hayward, California, 94545...Phone Number
(341) 777-0566Website
www.eikontx.comRevenue
$63.4 MillionIndustry
Most Recent Scoops
Highlights
$771.8M
Total Funding Amount
$106M
Most Recent Funding Amount
4
Number of Funding Rounds
Who is Eikon Therapeutics
Eikon Therapeutics Org Chart
Is Eikon Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Eikon Therapeutics has new funding data
Earning: See what the market has to say on Eikon Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Eikon Therapeutics
Eikon Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Eikon Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Eikon Therapeutics is spiking on competitors!
Product Launch: Get notified when Eikon Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Eikon Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Eikon Therapeutics
Find 3 more new buyers
Compare Similar Companies to Eikon Therapeutics
Compare insights from companies similar to Eikon Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Eikon Therapeutics
Eikon Therapeutics financials insights
Gather financial insights about Eikon Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Eikon Therapeutics Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Eikon Therapeutics Tech Stack
A closer look at the technologies used by Eikon Therapeutics
Most Recent Scoops
Eikon Therapeutics News & Media
Eikon Therapeutics Announces Appointment of Michael Klobuchar as Chief Operating Officer
HAYWARD, Calif.--(BUSINESS WIRE)-- #Biotech--Michael A. Klobuchar has been appointed Chief Operating Officer of Eikon Therapeutics.Eikon Therapeutics Management to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
HAYWARD, Calif.--(BUSINESS WIRE)-- #Biotech--Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, today announced that CEO and Board Chair, Roger M. Perlmutter, M.D., Ph.D., and CFO, Alfred “Freddie” Bowie, Ph.D., will provide a business update at Morgan Stanley’s 22nd Annual Global Healthcare Conference in New York City on September 4, 2024 at 8:30am ET. Their presentation will cover recent advancements in thEikon Therapeutics Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
HAYWARD, Calif.--(BUSINESS WIRE)-- #ASCO24--Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, announced today that multiple abstracts highlighting its clinical-stage TLR 7/8 co-agonist (EIK1001) and PARP1-selective inhibitor (EIK1003) programs will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, being held in Chicago May 31 – June 4, 2024. The oral presentation (AbstracEikon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
HAYWARD, Calif.--(BUSINESS WIRE)-- #Biotech--Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, today announced that CEO and Board Chair, Roger M. Perlmutter, M.D., Ph.D., will provide a business update highlighting pipeline and clinical development progress in a presentation at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 9:00 AM Pacific Standard Time. Additional informati
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Eikon Therapeutics
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases. Eikons discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes... Read More